Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

BACKGROUND: High-dose myeloablative conditioning prior to autologous hematopoietic stem cell transplantation (autoHSCT) in pediatric patients is usually highly emetogenic. The antiemetic neurokinin-1 receptor antagonist fosaprepitant was safe and effective in children receiving highly emetogenic che...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Cabanillas Stanchi, Karin Melanie, Willier, Semjon, Vek, Julia, Schlegel, Patrick, Queudeville, Manon, Rieflin, Nora, Klaus, Veronika, Gansel, Melanie, Rupprecht, Joachim Vincent, Flaadt, Tim, Binder, Vera, Feuchtinger, Tobias, Lang, Peter, Handgretinger, Rupert, Döring, Michaela
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524181/
https://ncbi.nlm.nih.gov/pubmed/33061297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S260887
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados